ISB News

Nature News: ‘Medicine Gets Up Close and Personal’ – Dr. Lee Hood’s Vision for Wellness

Infographic showing types of data

"Even in its pilot phase, the project is unusually thorough. The ISB will sequence the whole genome of each participant at the outset. And in later phases, Hood says, the study team will also examine epigenetics: methylation and other modifications to DNA that can reflect environmental exposures. But that is just the tip of the data-collection iceberg." — From 'Medicine Gets Up Close and Personal' in Nature

The journal Nature pubished a news article today (online Feb. 11, 2014/print Feb. 12, 2014) about Dr. Lee Hood's vision for the 100K Wellness Project. The project will launch in March first with a 100-person study that eventually will scale to 100,000 individuals. Read the Nature article, written by W. Wayt Gibbs, at this link.

To learn more, watch a video of Dr. Lee Hood talk about his vision for the 100K Wellness Project:

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.